Severe Dupilumab-Associated Psoriasis Flare After Switching From Ustekinumab for Biopsy-Proven Eczematous Dermatitis: A Case Report. (PubMed, Cureus) - Sep 10, 2026 - "Clinical improvement was achieved after restarting ustekinumab and methotrexate. This case highlights the potential for dupilumab to trigger severe paradoxical psoriasis in patients with pre-existing psoriatic disease. Clinicians should remain vigilant when prescribing dupilumab in this population, and early recognition with prompt modification of therapy may lead to favorable clinical outcomes."
Journal • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Psoriasis
|
|
Abdullah Alshatti; Bader Alflaij; Dana Alobaid; Doaa AlAwadhi; Fahad AlSharhan; Fatemah Abdulrahman; Fawziah AlRujaib; Munirah F AlEnezi; Reem Alqusaimi; Suad Alassaf
|